Warning: The NCBI web site requires JavaScript to function. more...
Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes.
Moore RA, Derry S, McQuay HJ.
Arthritis Res Ther. 2008;10(1):R7. Epub 2008 Jan 17. Review.
Related citations
The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.
Hooper L, Brown TJ, Elliott R, Payne K, Roberts C, Symmons D.
BMJ. 2004 Oct 23;329(7472):948. Epub 2004 Oct 8. Review.
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.
Health Technol Assess. 2008 Apr;12(11):1-278, iii. Review.
Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials.
Bjordal JM, Ljunggren AE, Klovning A, Slørdal L.
BMJ. 2004 Dec 4;329(7478):1317. Epub 2004 Nov 23. Review.
Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
Strand V.
Lancet. 2007 Dec 22;370(9605):2138-51. Review.
Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
Elnachef N, Scheiman JM, Fendrick AM, Howden CW, Chey WD.
Aliment Pharmacol Ther. 2008 Nov 15;28(10):1249-58. Epub 2008 Aug 22.
Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.
Rostom A, Dubé C, Lewin G, Tsertsvadze A, Barrowman N, Code C, Sampson M, Moher D; U.S. Preventive Services Task Force.
Ann Intern Med. 2007 Mar 6;146(5):376-89. Review.
Systematic review: the lower gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs.
Laine L, Smith R, Min K, Chen C, Dubois RW.
Aliment Pharmacol Ther. 2006 Sep 1;24(5):751-67. Review.
Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.
Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C.
BMJ. 2006 Jun 3;332(7553):1302-8.
Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
El Miedany Y, Youssef S, Ahmed I, El Gaafary M.
Ann Allergy Asthma Immunol. 2006 Jul;97(1):105-9.
Role of misoprostol in reducing aspirin-induced gastrointestinal blood loss in arthritic patients.
Ryan JR, Vargas R, Clay GA, McMahon FG.
Am J Med. 1987 Jul 27;83(1A):41-6.
Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review.
Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW.
Spine (Phila Pa 1976). 2008 Jul 15;33(16):1766-74. Review.
Effect of clopidogrel on naproxen-induced gastrointestinal blood loss in healthy volunteers.
van Hecken A, Depré M, Wynants K, Vanbilloen H, Verbruggen A, Arnout J, Vanhove P, Cariou R, De Schepper PJ.
Drug Metabol Drug Interact. 1998;14(3):193-205.
Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies.
Straube S, Derry S, McQuay HJ, Moore RA.
Acta Anaesthesiol Scand. 2005 May;49(5):601-13. Review.
The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
Goldstein JL, Lowry SC, Lanza FL, Schwartz HI, Dodge WE.
Aliment Pharmacol Ther. 2006 May 15;23(10):1489-98.
Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?
Kefalakes H, Stylianides TJ, Amanakis G, Kolios G.
Eur J Clin Pharmacol. 2009 Oct;65(10):963-70. Epub 2009 Aug 27. Review.
Non-steroidal anti-inflammatory drugs for low back pain.
Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000396. Review.
NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Fiorucci S, Santucci L, Distrutti E.
Dig Liver Dis. 2007 Dec;39(12):1043-51. Epub 2007 Nov 7. Review.
Time course and pattern of blood loss with ibuprofen treatment in healthy subjects.
Bowen B, Yuan Y, James C, Rashid F, Hunt RH.
Clin Gastroenterol Hepatol. 2005 Nov;3(11):1075-82.
Optimal assessment of gastrointestinal side effects induced by non-steroidal anti-inflammatory drugs. Endoscopic lesions, faecal blood loss, and symptoms not necessarily correlated, as observed after naproxen and oxindanac in healthy volunteers.
Aabakken L, Dybdahl JH, Eidsaunet W, Haaland A, Larsen S, Osnes M.
Scand J Gastroenterol. 1989 Oct;24(8):1007-13.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on